Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/16/24
End: 09/29/24
Due: 09/29/25
Phase: N/A
Priority: Normal
Start: 05/22/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 11/17/23
End: 11/30/25
Due: 11/30/26
Phase: N/A
Priority: Normal
Start: 07/24/23
End: 03/31/27
Due: 03/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers | NCT06462326 | Zai Lab (Hong Kong), Ltd. | user2@example.com | None | 2024-04-16 | 2024-09-29 | 2025-09-29 | - | - | 2025-07-14 |
| A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis | NCT06380907 | Zai Lab (Hong Kong), Ltd. | user2@example.com | None | 2024-05-22 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |
| A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP | NCT06162286 | Zai Lab (Hong Kong), Ltd. | user2@example.com | None | 2023-11-17 | 2025-11-30 | 2026-11-30 | - | - | 2025-07-14 |
| A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors | NCT05859464 | Zai Lab (Hong Kong), Ltd. | user2@example.com | None | 2023-07-24 | 2027-03-31 | 2028-03-31 | - | - | 2025-07-14 |